You are here

Our science / Clinical Trials / Find a Trial / NCT00900952

Epidemiologic Study Evaluating Infections in Elderly Patients

Back to Search Print Save as PDF Bookmark Trial

NCT00900952

Last updated on February 23, 2020
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Mataró, Barcelona, 08304 Spain
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
65 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients > 65 years of age that are hospitalized in an Internal Medicine ward and
have an active infection (skin and soft tissue, intra-abdominal, or respiratory
infections) from the community that needs antibiotic treatment

- Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- COPD exacerbation

- Urinary tract infections

- Hospital acquired infections

- Other infections not in inclusion criteria

NCT00900952
Pfizer
Completed
Epidemiologic Study Evaluating Infections in Elderly Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Infection
Real-World Observational Study Of Zavicefta to Characterize Use Patterns
NCT03923426
All Genders
18+
Years
Angers,
Community Acquired Pneumonia, Complicated Skin and Soft Tissue Infection
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
NCT04198571
All Genders
Pneumococcal Infections, COPD
Immunization To Prevent Acute COPD Exacerbations
NCT03276754
All Genders
18+
Years
Multiple Sites
Respiratory Tract Infection
A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
NCT04032093
Females
18+
Years
Multiple Sites
Descriptive Information
Brief Title Epidemiologic Study Evaluating Infections in Elderly Patients
Official Title Epidemiologic Study of Infections in Elderly Patients
Brief Summary The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Infected elderly patients treated at Internal Medicine wards in Spanish hospitals
Condition Infection
Intervention Other: Clinical record review
Study Groups/Cohorts 1
Infected elderly patients
Intervention: Other: Clinical record review
Publications * Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: October 8, 2009) 		240
Original Estimated Enrollment
 (submitted: May 12, 2009) 		500
Actual Study Completion Date June 2009
Actual Primary Completion Date June 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion criteria:

  • Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment
  • Patients must have at least one sample processed for microbiological diagnosis

Exclusion criteria:

  • COPD exacerbation
  • Urinary tract infections
  • Hospital acquired infections
  • Other infections not in inclusion criteria
Sex/Gender
Sexes Eligible for Study: All
Ages 65 Years and older   (Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Spain
Removed Location Countries  
 
Administrative Information
NCT Number NCT00900952
Other Study ID Numbers 3074X1-4489
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
Study Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators Not Provided
Investigators
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
PRS Account Wyeth is now a wholly owned subsidiary of Pfizer
Verification Date October 2009

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]com

Call Now